No doubt about it, Scott is very likeable and is very clear and succinct about EMV. He was the perfect replacement for Ron from whom he would have learnt plenty.With Stuart Crozier being in our corner and 2/3 of his technology used in MRIs I am certain he knows exactly what needs doing to get approvals for EMV and our emu.
Minimal dilution is also a huge plus, getting taken over in 12 months time wouldn’t surprise me pending FDA.Regardless this is a very exciting year for shareholders,GLTAH, roll on 2024.
EMvision Research Notes, page-2250
-
- There are more pages in this discussion • 332 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.99 |
Change
0.020(1.02%) |
Mkt cap ! $169.9M | |||
| Open | High | Low | Value | Volume |
| $1.93 | $1.99 | $1.92 | $22.44K | 11.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.99 | 2904 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| EMV (ASX) Chart |